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Gord Fishell is a professor and associate director of the NYU Neuroscience Institute, which he was central in creating as a founding member. His laboratory is interested in the developmental steps that allow the startling repertoire of inhibitory GABAergic interneurons to integrate in the brain. As the link between interneurons and psychiatric disease has become more apparent, his work has increasingly spanned the boundary between development and disease. This is a logical extension of his scientific career, which for the past 20 years has bridged the fields of developmental genetics and physiology. This experience has fomented his strong belief that a genetic understanding of interneurons will lead to novel treatments for psychiatric disease. Dr. Fishell's interest in development began during his PhD in the neurobiology program at the University of Toronto. He did a postdoctoral fellowship at Columbia University before going on to a brief 2-year stint as an assistant professor at the Rockefeller University. He then joined the newly founded Skirball Developmental Genetics Program at the NYU Medical Center in 1994 and remained there for 10 years until he founded the Smilow Neuroscience program, which in 2012 merged with the NYU Neuroscience institute. Dr. Fishell has been a Simons Investigator since 2007, gave a Society of Neuroscience Presidential Lecture in 2014, and is the recipient of the Merson and Shucart prizes. He is a standing member of the Novartis FMI advisory board and is on the council of NIH's National Institute of Neurological Disorders and Stroke.
What do you think are the big questions to be answered next in your field? The cerebral cortex represents in physical form the embodiment of what makes us human. Understanding both how neocortical circuits are assembled and the logic by which they process information represents a fundamental challenge in the goal of deciphering the biological basis of cognition. The circuits that comprise it are assembled over a brief perinatal period and emerge within pre-patterned regions specialized for the highest-order representation of sensation, action, and cognition. From a developmental standpoint, the interplay between intrinsic genetic programs and extrinsic activity allow these circuits to be precisely patterned in a manner that appears iterative. This suggests that a common set of interactions defines how the laminar and columnar circuitries are formed. However, it remains unclear whether qualitative differences or repurposing of a common architecture (with relatively minor differences in laminar thickness and topographic organization) allow for regional differences in the representation of vision, touch, sound, motor action, and executive function. Are there common motifs and cell types in the wiring and flow of information in different cortical areas? Do the regional-specific rules change the type and number of cells that populate it? Is synaptic connectivity hardwired or shaped by activity? Is there a fundamental difference between the mechanisms that prune circuits during development and the plasticity that allows for learning? Any attempts to understand how the cortex mediates the complex behaviors that define us as individuals will require understanding these fundamental questions about how these circuits are created during development.
Which aspect of science, your field or in general, do you wish the general public knew more about? I often muse at my great luck in being born at a time when our ability to probe the brain has undergone such a profound revolution. When I was a graduate student, the idea of visualizing the expression of a gene or protein in vivo was revolutionary. The idea that we could use genetics to mark, query, and manipulate neuronal function was unthinkable. This has clearly changed for basic neuroscience, but from a public health perspective, we haven't yet seen a major impact. In fact, the general public experienced the first great revolution in treating neuropsychiatric disease in the 1950s and our treatment of these diseases hasn't substantially changed since the 1970s. It is therefore understandable that there would be some public frustration about the continued optimism basic research is projecting. I think if we can figure out a way to infuse our conviction into the lay person that an overwhelming change is coming in our ability to understand and treat brain disease, their enthusiasm for basic science will skyrocket accordingly.
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To tackle your favorite research question, is there a tool that either needs to be developed or is currently available that could be implemented in a novel way? Genetics has experienced amazing progress over the past 20 years but our understanding of bio-and protein chemistry has yet to follow suit. Neurons represent the most specialized cells in the body and are able to function due to the coordination of proteins complexes in ways we are now only beginning to understand. New tools to be able to examine the range, interactions, and functions of proteins rely on methods that pale compared to the precision with which we can manipulate genes. If we had methods that allowed us to quantitatively track protein number, interactions, and activity, it would provide insights into neuronal function equal to what the genetic revolution has yielded. Do you have a favorite anecdote from doing science that you'd like to share (perhaps a key discovery moment)? During the first years I had a lab, my first postdoc, Jhumku Kohtz, experienced serendipity. Jhumku was studying the function of the protein Sonic Hedgehog (Shh) in the telencephalon. She had been using recombinant Shh from the Jessell laboratory to ventralize forebrain tissue explants and ran out of her stock. We got more that didn't work from Ontogeny and she realized the old stock had been made using Bacalovirus but the new stock had been made in bacteria. On a hunch, she ran the aliquots from both sources on a gel and noticed that the eukaryote-derived Shh had slightly lower mobility, and on that basis announced at floor meeting that she believed that there was a post-translational modification that was critical for Shh function. She hadn't shown me this data beforehand and both I and the entire program were deeply skeptical. We then collaborated with Biogen who had in fact discovered just such a secondary modification to Shh. It was palmitoylated, and just as Jhumku had surmised the palmitoylation was essential for Shh activity in her assay. Some years later when Sightless, the palmitoylase required to modify Shh, was knocked out, it had precisely the defect in ventral forebrain Jhumku had predicted.
What has been the highlight of your career? In 2002 I had just been granted tenure at NYU and was looking for a new challenge beyond the early signaling and patterning mechanisms I had been studying. I had been long fascinated by the transient progenitor zones within the ventral embryonic forebrain. When work from Stewart Anderson and John Rubenstein showed that the inhibitory interneurons that populate the cortex came from these regions, it made me all the more eager to understand them. So when Arturo Alvarez Buylla came to me eager to fate map them, I was immediately game. From these experiments, it became clear that different interneuron types came from different ventral progenitor regions. Although I knew virtually nothing about this cell type at the time, in reading the work of physiologists, it became obvious that their function within neural circuits was both central and diverse. The decision to pursue the origins of these cells has led to the entire focus of my laboratory and quite simply this highlight has remained with me to the present.
Who were your key early influences?
Having completed my PhD on patterning in the striatum, in a system I could describe but not manipulate, I became fascinated by the work of Andrew Lumsden, who had interrogated the intrinsic fate of hindbrain segments in the chick through transplantation. By chance I met him at a meeting in 1994 and when I expressed my enthusiasm for his work, he invited me to come to do a mini-sabbatical in his lab in London. Although I only spent 2 weeks in his laboratory and my efforts to learn grafting in chick were at best meager, his pioneer spirit of biological experimentation was instrumental in how I have approached problems to this day.
What motivated you to become a scientist?
The short answer is hard science fiction, the extrapolation of science to possibility. In particular, the ideas of Philip K. Dick, recognizing that our sense of self is entirely reliant on the internal representation of the external world that our brains create, fascinated me as a teenager. In particular, two of his books that were made into movies, Blade Runner (Do Androids Dream of Electric Sheep) and Total Recall (We Can Remember that for You Wholesale), first sparked my interest in the question of consciousness. The longer answer is December 16, 1983. I had on a whim done a science rotation as an undergraduate and my project was to look at early connectivity between the striatum and the substantia nigra. December 16 th was the day of the holiday party and coincided with me finishing this experiment. Instead of heading to the party, I went to the microscope and looking at my slides I saw that the early-born striasome cells that selectively received dopaminergic inputs also were the first to project to the substantia nigra. That I could know something in a moment that at that time no one in the world knew was a thrill beyond any I had ever experienced.
What do you think are the biggest problems/challenges science as a whole is facing today? Perhaps the greatest challenge is simply resisting the temptation to veer away from ''blue sky'' research in favor of applied science. Efforts focused entirely on examining basic mechanisms are always a hard sell for the public. Without an end goal, such efforts are intrinsically hardest to justify but without them everything from CRISPR to the Higgs Boson would remain undiscovered. How do you view the level of crosstalk between disciplines, (for example physics, mathematics, engineering, humanities, and social science)? The era of department-specific science is over and good riddance. Just as the various forms of genetic reporters and effectors have transformed systems neuroscience, the need to deal with large datasets is changing the way biologists look at their data. There is a now a striking parallel between system neuroscientists using PCA for spike sorting and geneticists who use it to plot gene trajectories. This trend will only continue, with a stronger link to engineering and biology being what I suspect will comprise the next major shift. Given that neuroscience as a discipline really began with the ancient philosophers, there is a poetic beauty in the fact that a modern role for them in both discussions of consciousness and ethics is soon coming.
Where do you see the strongest potential for progress and new breakthroughs in neuroscience? When considering information flow through the nervous system, even neuroscientists sometimes forget the rapidly converging and diverging nature of signaling utilized in our brains. To make a back of the envelope calculation, let's assume that a typical neuron receives upward of a thousand inputs from one to three hundred afferent cells. Activation of such a neuron would require coordinate inputs from 30 to 60 afferent synapses impinging on that neuron over a suitably short period. Given the availability of a thousand such synapses, a given cell could be recruited in many, many ways. Of course this process is iterative and repeats itself at the efferent targets of this same neuron. In the face of such signaling, how can we hope to understand and, even more so, meaningfully modify brain activity? At the heart of such aspirations lies the ability to target and manipulate input/output functions of specific populations of neurons in vivo. This would get at how identified neurons embedded within circuits use their biophysical and synaptic properties to perform actual computations. This has been possible in fruit flies, and modern genetics is on the verge of making this possible in mammals and even in nongenetic model organisms. With such an advance, the ability to begin to plumb brain function by altering recruitment of specific populations in awake-behaving animals is becoming tractable. Systematic exploration of brain circuits from the vantage of specific cell types promises to dramatically increase both our ability to understand brain function. It also opens up the promise of treating neuropsychiatric dysfunction through the therapeutic modulation of circuits.
What advice do you find yourself giving to your students and postdocs? Don't assume you can guess the answers, and getting a result you don't expect is often the best result you can hope for. Realize how little we know and that discovery rather than being a long shot is around every corner if one can only look at data with fresh eyes and cast off the prejudices of a priori hypotheses.
Do you have a role model in science? If so, who and why? Role model perhaps is the wrong word but there are certainly scientists I enormously admire. These include Alan Turing, Alan Hodgkin, Andrew Huxley, Steven Kuffler, Sydney Brenner, and Seymour Benzer. A thread that links them together is the fact they are all consummate model builders who recognized the need to have a quantitative vision of the system they were studying to make predictions. Their collective approach and the success that each of them made by following it demonstrates that only by taking a holistic approach can one deconvolve biology's complexity.
Did you encounter particular difficulties? How did you overcome them? Through my graduate work I fell in love with the wonderful complexity of the nervous system. My PhD, which focused on the emergence of the striasome-matrix organization of the striatum, enthralled me with its precision and intricacy. It also deeply frustrated me, as at the time we lacked the experimental methods to figure out the underlying biological mechanisms leading to its formation. It seemed at the end of my PhD that there then existed two possible paths to tackle this question. One was to take the systematic approach of identifying the critical genes involved followed by genetic loss-offunction analysis. Alternatively one might develop reductionist systems where the cellular interactions between component neurons might be examined to better understand the complex structures they contribute to. At the time we thought there might be as many as 100,000 genes and only three or four knockouts had been generated. Fearing I would spend my postdoc producing a single knockout that might have no interesting phenotype, I opted for taking a reductionist cellular approach. After 5 years as a postdoc, I got my first tenure track faculty job and realized my mistake. Transforming my laboratory from one focused on cell biology to one using genetics took 6 years and took a huge leap of faith. Difficult as that period was, it was one of the most gratifying periods of my career.
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